We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 778

Supreme Court declines to hear Eli Lilly’s “promise of the patent” appeal

  • Bereskin & Parr LLP
  • -
  • Canada
  • -
  • May 16 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Eli Lilly Canada Inc v Novopharm Ltd

What goes upmust come down: Viagra patent invalidated by Canadian Supreme Court

  • Drinker Biddle & Reath LLP
  • -
  • Canada
  • -
  • May 13 2013

Pfizer and Teva have been fighting a legal battle over Pfizer's patent for Viagra in Canada. The first shot was fired when Novopharm Limited, now

Ambulance service failed in duty to accommodate - manager also personally liable

  • McCarthy Tétrault LLP
  • -
  • Canada
  • -
  • May 10 2013

The BC Ambulance Service failed in its duty to accommodate a paramedic who could no longer palpate a pulse because of his mulitple sclerosis. The

Supreme Court of Canada denies leave to appeal in PM(NOC) judicial comity case

  • Bereskin & Parr LLP
  • -
  • Canada
  • -
  • May 9 2013

The Supreme Court of Canada denied leave to appeal today from the Federal Court of Appeal ("FCA") decision in Allergan Inc. et al ats. Apotex Inc

Dispelling the Myriad gene patent harmonization myth

  • Foley & Lardner LLP
  • -
  • Australia, Canada, European Union, France, Germany, Japan, USA
  • -
  • April 30 2013

In the wake of the Supreme Court oral arguments in the Myriad "gene patent" case, most commentators are predicting that the Court will uphold the

Legal causation and the duty to warn

  • McCarthy Tétrault LLP
  • -
  • Australia, Canada
  • -
  • May 8 2013

Can a defendant be liable for failing to warn about a risk which does not materialize, where this leads the plaintiff to be injured by a second

Generic ordered to pay $1.7 million in accounting of profits

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 22 2013

On March 12, 2013, the Federal Court released its decision in Apotex Inc. v. H. Lundbeck AS, 2013 FC 192. The Court dismissed Apotex's action to

Plaintes d’usagers en milieu hospitalier : la Cour précise les conséquences de l’expiration du délai de traitement

  • Heenan Blaikie LLP
  • -
  • Canada
  • -
  • April 30 2013

Depuis quelque temps, plusieurs comités de discipline constitués pour étudier les plaintes portées à l'endroit de

Federal Court sets aside PMPRB decision regarding COPAXONE syringes for the second time

  • Smart & Biggar/Fetherstonhaugh
  • -
  • Canada
  • -
  • May 7 2013

On April 30, 2013, Justice Zinn of the Federal Court set aside a decision of the PMPRB (the "Board"), which ordered (Order, Reasons) Teva to pay the

Mylan Pharmaceuticals ULC v. Pfizer Canada Inc., 2012 FCA 103 - Aricept (donepezil), appeal of NOC case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 3 2012

The Court of Appeal upheld on Order prohibiting the Minister of Health from issuing a NOC to Mylan for donepezil, a drug for the treatment of Alzheimer's type dementia, until expiry of Pfizer’s ‘808 Patent

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy